Are we treating enough elderly patients with early stage non-small cell lung cancer?

Lung Cancer

Volumn 74, Issue 2, 2011, Pages 149-154

  Pallis, A G ^a   Scarci, M ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Elderly; Non small cell lung cancer; Radiotherapy; Stage; Surgery

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; ELDERLY CARE; EVIDENCE BASED MEDICINE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MORTALITY; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; COMORBIDITY; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY;

EID: 80053655288     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.025     Document Type: Review

References (90)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
3. Wingo P.A., Cardinez C.J., Landis S.H., Greenlee R.T., Ries L.A., Anderson R.N., et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 2003, 97(12 Suppl.):3133-3275.
4. Havlik R.J., Yancik R., Long S., Ries L., Edwards B. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994, 74(7 Suppl.):2101-2106.
5. Gridelli C., Perrone F., Monfardini S. Lung cancer in the elderly. Eur J Cancer 1997, 33(14):2313-2314.
6. Yang P., Allen M.S., Aubry M.C., Wampfler J.A., Marks R.S., Edell E.S., et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005, 128(1):452-462.
7. Marino P., Pampallona S., Preatoni A., Cantoni A., Invernizzi F. Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. Chest 1994, 106(3):861-865.
8. NCCN Clinical Practice Guidelines in Oncology. v.2.2010 Non-Small-Cell Lung Cancer. http://www%20nccn%20org/professionals/physician_gls/f_guidelines%20asp%202010.
9. Winton T., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005, 352(25):2589-2597.
10. Douillard J.Y., Rosell R., De L.M., Carpagnano F., Ramlau R., Gonzales-Larriba J.L., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006, 7(9):719-727.
11. Pignon J.P., Tribodet H., Scagliotti G.V., Douillard J.Y., Shepherd F.A., Stephens R.J., et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008, 26(21):3552-3559.
12. Strauss G.M., Herndon J.E., Maddaus M.A., Johnstone D.W., Johnson E.A., Harpole D.H., et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008, 26(31):5043-5051.
13. Kumar A., Soares H.P., Balducci L., Djulbegovic B. Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups. J Clin Oncol 2007, 25(10):1272-1276.
14. Hutchins L.F., Unger J.M., Crowley J.J., Coltman C.A., Albain K.S. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999, 341(27):2061-2067.
15. Lewis J.H., Kilgore M.L., Goldman D.P., Trimble E.L., Kaplan R., Montello M.J., et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003, 21(7):1383-1389.
16. Talarico L., Chen G., Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004, 22(22):4626-4631.
17. Dale D.C. Poor prognosis in elderly patients with cancer: the role of bias and undertreatment. J Support Oncol 2003, 1(4 Suppl. 2):11-17.
18. Fentiman I.S., Tirelli U., Monfardini S., Schneider M., Festen J., Cognetti F., et al. Cancer in the elderly: why so badly treated?. Lancet 1990, 335(8696):1020-1022.
19. Scott W.J., Howington J., Feigenberg S., Movsas B., Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(3 Suppl.):234S-242S.
20. Lim E., Baldwin D., Beckles M., Duffy J., Entwisle J., Faivre-Finn C., et al. Guidelines on the radical management of patients with lung cancer. Thorax 2010, 65(Suppl. 3):iii1-27.
21. Sigel K., Bonomi M., Packer S., Wisnivesky J. Effect of age on survival of clinical stage I non-small-cell lung cancer. Ann Surg Oncol 2009, 16(7):1912-1917.
22. O'Connell J.B., Maggard M.A., Ko C.Y. Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol 2004, 11(11):962-969.
23. Owonikoko T.K., Ragin C.C., Belani C.P., Oton A.B., Gooding W.E., Taioli E., et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2007, 25(35):5570-5577.
24. Cykert S., lworth-Anderson P., Monroe M.H., Walker P., McGuire F.R., Corbie-Smith G., et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 2010, 303(23):2368-2376.
25. Mery C.M., Pappas A.N., Bueno R., Colson Y.L., Linden P., Sugarbaker D.J., et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005, 128(1):237-245.
26. Pallis A.G., Gridelli C., van Meerbeeck J.P., Greillier L., Wedding U., Lacombe D., et al. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. Ann Oncol 2010, 21(4):692-706.
27. Ciriaco P., Zannini P., Carretta A., Melloni G., Chiesa G., Canneto B., et al. Surgical treatment of non-small cell lung cancer in patients 70 years of age or older. Int Surg 1998, 83(1):4-7.
28. Thomas P., Piraux M., Jacques L.F., Gregoire J., Bedard P., Deslauriers J. Clinical patterns and trends of outcome of elderly patients with bronchogenic carcinoma. Eur J Cardiothorac Surg 1998, 13(3):266-274.
29. Pagni S., McKelvey A., Riordan C., Federico J.A., Ponn R.B. Pulmonary resection for malignancy in the elderly: is age still a risk factor?. Eur J Cardiothorac Surg 1998, 14(1):40-44.
30. Oliaro A., Leo F., Filosso P.L., Rena O., Parola A., Maggi G. Resection of bronchogenic carcinoma in the elderly. J Cardiovasc Surg (Torino) 1999, 40(5):715-719.
31. Sioris T., Salo J., Perhoniemi V., Mattila S. Surgery for lung cancer in the elderly. Scand Cardiovasc J 1999, 33(4):222-227.
32. Kamiyoshihara M., Kawashima O., Ishikawa S., Morishita Y. Long-term results after pulmonary resection in elderly patients with non-small cell lung cancer. J Cardiovasc Surg (Torino) 2000, 41(3):483-486.
33. Conti B., Brega Massone P.P., Lequaglie C., Magnani B., Cataldo I. Major surgery in lung cancer in elderly patients? Risk factors analysis and long-term results. Minerva Chir 2002, 57(3):317-321.
34. Yamamoto K., Padilla A.J., Calvo M.V., Garcia-Zarza A., Pastor G.J., Blasco A.E., et al. Surgical results of stage I non-small cell lung cancer: comparison between elderly and younger patients. Eur J Cardiothorac Surg 2003, 23(1):21-25.
35. Birim O., Zuydendorp H.M., Maat A.P., Kappetein A.P., Eijkemans M.J., Bogers A.J. Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg 2003, 76(6):1796-1801.
36. Sawada S., Komori E., Nogami N., Bessho A., Segawa Y., Shinkai T., et al. Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition. Chest 2005, 128(3):1557-1563.
37. Yazgan S., Gursoy S., Yaldiz S., Basok O. Outcome of surgery for lung cancer in young and elderly patients. Surg Today 2005, 35(10):823-827.
38. Cerfolio R.J., Bryant A.S. Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study. Ann Thorac Surg 2006, 82(2):424-429.
39. Sullivan V., Tran T., Holmstrom A., Kuskowski M., Koh P., Rubins J.B., et al. Advanced age does not exclude lobectomy for non-small cell lung carcinoma. Chest 2005, 128(4):2671-2676.
40. Sirbu H., Schreiner W., Dalichau H., Busch T. Surgery for non-small cell carcinoma in geriatric patients: 15-year experience. Asian Cardiovasc Thorac Ann 2005, 13(4):330-336.
41. Dyszkiewicz W., Pawlak K., Gasiorowski L. Early post-pneumonectomy complications in the elderly. Eur J Cardiothorac Surg 2000, 17(3):246-250.
42. Spaggiari L., Scanagatta P. Surgery of non-small cell lung cancer in the elderly. Curr Opin Oncol 2007, 19(2):84-91.
43. Goodgame B., Viswanathan A., Zoole J., Gao F., Miller C.R., Subramanian J., et al. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients. J Thorac Oncol 2009, 4(11):1370-1374.
44. Okami J., Higashiyama M., Asamura H., Goya T., Koshiishi Y., Sohara Y., et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol 2009, 4(10):1247-1253.
45. Hanagiri T., Muranaka H., Hashimoto M., Nagashima A., Yasumoto K. Results of surgical treatment of lung cancer in octogenarians. Lung Cancer 1999, 23(2):129-133.
46. Muraoka M., Oka T., Akamine S., Tagawa T., Sasaki N., Ikuta Y., et al. Surgical treatment for lung cancer in octogenarians. Surg Today 2005, 35(9):725-731.
47. Matsuoka H., Okada M., Sakamoto T., Tsubota N. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. Eur J Cardiothorac Surg 2005, 28(3):380-383.
48. Dominguez-Ventura A., Cassivi S.D., Allen M.S., Wigle D.A., Nichols F.C., Pairolero P.C., et al. Lung cancer in octogenarians: factors affecting long-term survival following resection. Eur J Cardiothorac Surg 2007, 32(2):370-374.
49. Aoki T., Yamato Y., Tsuchida M., Watanabe T., Hayashi J., Hirono T. Pulmonary complications after surgical treatment of lung cancer in octogenarians. Eur J Cardiothorac Surg 2000, 18(6):662-665.
50. Brock M.V., Kim M.P., Hooker C.M., Alberg A.J., Jordan M.M., Roig C.M., et al. Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience. Ann Thorac Surg 2004, 77(1):271-277.
51. Port J.L., Kent M., Korst R.J., Lee P.C., Levin M.A., Flieder D., et al. Surgical resection for lung cancer in the octogenarian. Chest 2004, 126(3):733-738.
52. Wada H., Nakamura T., Nakamoto K., Maeda M., Watanabe Y. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 1998, 115(1):70-73.
53. Janssen-Heijnen M.L., Maas H.A., Houterman S., Lemmens V.E., Rutten H.J., Coebergh J.W. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer 2007, 43(15):2179-2193.
54. Jaklitsch M.T., Mery C.M., Audisio R.A. The use of surgery to treat lung cancer in elderly patients. Lancet Oncol 2003, 4(8):463-471.
55. Groth S.S., Rueth N.M., Hodges J.S., Habermann E.B., Andrade R.S., D'Cunha J., et al. Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer. Ann Thorac Surg 2010, 90(2):375-382.
56. van Meerbeeck J.P., Damhuis R.A., Vos de Wael M.L. High postoperative risk after pneumonectomy in elderly patients with right-sided lung cancer. Eur Respir J 2002, 19(1):141-145.
57. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001, 56(2):89-108.
58. Burfeind W.R., Tong B.C., O'Branski E., Herndon J.E., Toloza E.M., D'Amico T.A., et al. Quality of life outcomes are equivalent after lobectomy in the elderly. J Thorac Cardiovasc Surg 2008, 136(3):597-604.
59. Schulte T., Schniewind B., Walter J., Dohrmann P., Kuchler T., Kurdow R. Age-related impairment of quality of life after lung resection for non-small cell lung cancer. Lung Cancer 2010, 68(1):115-120.
60. Balduyck B., Hendriks J., Lauwers P., Sardari N.P., Van S.P. Quality of life evolution after lung cancer surgery in septuagenarians: a prospective study. Eur J Cardiothorac Surg 2009, 35(6):1070-1075.
61. Salati M., Brunelli A., Xiume F., Refai M., Sabbatini A. Quality of life in the elderly after major lung resection for lung cancer. Interact Cardiovasc Thorac Surg 2009, 8(1):79-83.
62. Hurria A., Kris M.G. Management of lung cancer in older adults. CA Cancer J Clin 2003, 53(6):325-341.
63. Sibley G.S., Jamieson T.A., Marks L.B., Anscher M.S., Prosnitz L.R. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998, 40(1):149-154.
64. Cheung P.C., Mackillop W.J., Dixon P., Brundage M.D., Youssef Y.M., Zhou S. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2000, 48(3):703-710.
65. Gauden S.J., Tripcony L. The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population. Lung Cancer 2001, 32(1):71-79.
66. Hayakawa K., Mitsuhashi N., Katano S., Saito Y., Nakayama Y., Sakurai H., et al. High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 2001, 32(1):81-88.
67. Patterson C.J., Hocking M., Bond M., Teale C. Retrospective study of radiotherapy for lung cancer in patients aged 75 years and over. Age Ageing 1998, 27(4):515-518.
68. Pignon T., Gregor A., Schaake K.C., Roussel A., Van G.M., Scalliet P. Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 1998, 46(3):239-248.
69. Rowell N.P., Williams C.J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev 2001, (2). CD002935.
70. Palma D.A., Tyldesley S., Sheehan F., Mohamed I.G., Smith S., Wai E., et al. Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment?. J Thorac Oncol 2010, 5(6):818-824.
71. Berman A.T., Rengan R. New approaches to radiotherapy as definitive treatment for inoperable lung cancer. Semin Thorac Cardiovasc Surg 2008, 20(3):188-197.
72. Haasbeek C.J., Lagerwaard F.J., Antonisse M.E., Slotman B.J., Senan S. Stage I nonsmall cell lung cancer in patients aged > or=75 years: outcomes after stereotactic radiotherapy. Cancer 2010, 116(2):406-414.
73. Fruh M., Rolland E., Pignon J.P., Seymour L., Ding K., Tribodet H., et al. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. J Clin Oncol 2008, 26(21):3573-3581.
74. Pepe C., Hasan B., Winton T.L., Seymour L., Graham B., Livingston R.B., et al. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol 2007, 25(12):1553-1561.
75. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998, 352(9124):257-263.
76. Burdett S., Stewart L. Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 2005, 47(1):81-83.
77. Mayer R., Smolle-Juettner F.M., Szolar D., Stuecklschweiger G.F., Quehenberger F., Friehs G., et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 1997, 112(4):954-959.
78. Dautzenberg B., Arriagada R., Chammard A.B., Jarema A., Mezzetti M., Mattson K., et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 1999, 86(2):265-273.
79. Feng Q.F., Wang M., Wang L.J., Yang Z.Y., Zhang Y.G., Zhang D.W., et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 2000, 47(4):925-929.
80. Okawara G., Ung Y.C., Markman B.R., Mackay J.A., Evans W.K. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer 2004, 44(1):1-11.
81. Pisters K.M., Evans W.K., Azzoli C.G., Kris M.G., Smith C.A., Desch C.E., et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007, 25(34):5506-5518.
82. Jatoi A., Hillman S., Stella P., Green E., Adjei A., Nair S., et al. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 2005, 23(36):9113-9119.
83. Pallis A.G., Fortpied C., Wedding U., Van Nes M.C., Penninckx B., Ring A., et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 2010, 46(9):1502-1513.
84. Pallis A.G., Wedding U., Lacombe D., Soubeyran P., Wildiers H. Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know?. Eur J Cancer 2010, 46(6):1019-1025.
85. Christman K., Muss H.B., Case L.D., Stanley V. Chemotherapy of metastatic breast cancer in the elderly, The Piedmont Oncology Association experience. JAMA 1992, 268(1):57-62.
86. Belani C.P., Fossella F. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). Cancer 2005, 104(12):2766-2774.
87. Kohne C.H., Folprecht G., Goldberg R.M., Mitry E., Rougier P. Chemotherapy in elderly patients with colorectal cancer. Oncologist 2008, 13(4):390-402.
88. Repetto L., Venturino A., Fratino L., Serraino D., Troisi G., Gianni W., et al. Geriatric oncology: a clinical approach to the older patient with cancer. Eur J Cancer 2003, 39(7):870-880.
89. Repetto L., Fratino L., Audisio R.A., Venturino A., Gianni W., Vercelli M., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002, 20(2):494-502.
90. Wedding U., Kodding D., Pientka L., Steinmetz H.T., Schmitz S. Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol 2007, 64(1):1-9.